We explore Professor Leigh Charvet’s vast research within multiple sclerosis, consider her time working in industry compared with her experiences in…

In this episode, Dr Marina Garassino explores the unmet needs for patients living with EGFR-mutated non-small cell lung cancer (NSCLC).

Methotrexate has been established beyond doubt as the primary disease-modifying drug for the therapy of rheumatoid arthritis.

Hear from two experts, as they discuss the latest efficacy and safety data in patients with RET-driven thyroid cancer, RET testing, and the future of RET-driven diseases.

This novel, extensive publication by scientific experts describes the present situation regarding medicinal use…

Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, discusses patient advocacy and supporting carers.

This issue of EMJ Nephrology includes the latest peer-reviewed research alongside a review of the ERA–EDTA Congress 2021.